Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesBOD Science Ltd

BOD Science Ltd

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
None AUD 0.00(0%)
Last update at 2026-01-02T06:45:05.705016Z
Market Cap
4.26M

Momentum Score

…

Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. The company operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. It engages in the development of cannabidiol and hemp products for consumers; and development and distribution of therapeutics medicinal cannabis products for medical markets. The company provides Flexofytol, an anti-inflammatory derived from a scientifically validated and clinically trialed turmeric extract that helps in improving joint pain and stiffness, joint health, limiting the ageing of cartilage, and reducing inflammation caused by mild arthritis; and Sedistress, a passion flower extract that reduces the symptoms of stress, anxiety, and insomnia, as well as contract manufacturing services. The company was formerly known as Bod Australia Limited and changed its name to Bod Science Limited in December 2022. Bod Science Limited was incorporated in 2014 and is based in Double Bay, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.02
Low
0.02
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
3.32M
Revenue Per Share
0.02
Gross Profit TTM
2.27M
Debt / Equity
-0.31
ROE
-575.61%
Net Debt
0.50M
ROCE
184.38%
Diluted EPS TTM
-0.06

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -9.31M -5.41M -4.23M -4.82M -7.62M
Net income -7.95M -5.41M -4.23M -4.82M -7.62M
Selling general administrative 3.60M 3.48M 3.90M 2.58M 2.87M
Selling and marketing expenses 0.83M 1.09M 0.73M 0.86M 2.02M
Gross profit -3.08M 0.50M 2.66M 1.14M 0.29M
Reconciled depreciation 0.17M 0.15M 0.13M 0.07M 0.06M
Ebit -9.39M -5.89M -4.11M -3.67M -5.81M
Ebitda -9.22M -5.73M -3.98M -3.60M -5.75M
Depreciation and amortization 0.17M 0.15M 0.13M 0.07M 0.06M
Operating income -9.39M -5.89M -4.11M -3.67M -5.81M
Other operating expenses 11.11M 9.33M 10.66M 9.08M 7.24M
Interest expense 0.03M - 0.00M 0.00M 0.00M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 0.30M 0.01M 0.04M 0.04M 0.07M
Net interest income -0.01M 0.01M 0.02M 0.08M 0.07M
Income tax expense -1.36M 0.02M -0.04M 0.32M 0.54M
Total revenue 1.72M 3.42M 6.58M 5.01M 0.82M
Total operating expenses 6.32M 6.41M 6.74M 5.20M 6.71M
Cost of revenue 4.79M 2.93M 3.92M 3.88M 0.53M
Total other income expense net 0.08M 0.50M -0.16M -0.83M -1.27M
Net income from continuing ops -7.95M -5.41M -4.23M -4.82M -7.62M
Net income applicable to common shares -7.95M -5.41M -4.23M -4.82M -7.62M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 2.60M 2.31M 3.50M 5.31M 10.35M
Intangible assets 0.00M 0.02M 0.13M 0.42M 0.34M
Other current assets 0.92M 0.96M 0.18M 0.03M 0.03M
Total liab 7.75M 7.63M 4.21M 1.85M 1.69M
Total stockholder equity -5.15M -5.32M -0.70M 3.47M 8.66M
Deferred long term liab - - - 0.23M 0.31M
Other current liab 1.85M 1.37M 0.23M 0.63M 0.95M
Common stock 34.75M 34.75M 33.02M 29.40M 29.40M
Capital stock - - 33.02M 29.40M 29.40M
Retained earnings -40.63M -41.03M -37.24M -29.29M -23.88M
Other liab - - 0.59M 0.06M -
Other assets - 0.00M - 0.23M 0.31M
Cash 1.10M 0.43M 2.03M 3.67M 8.05M
Total current liabilities 7.69M 7.58M 3.62M 1.78M 1.69M
Current deferred revenue - 0.10M - - -
Net debt 0.50M 1.40M - -3.67M -8.05M
Short term debt 1.60M 1.83M 0.96M 0.00M 0.00M
Short long term debt - - 0.96M - -
Short long term debt total 1.60M 1.83M - - -
Other stockholder equity - - 3.52M 3.36M 3.15M
Property plant equipment - - 0.08M 0.02M 0.03M
Total current assets 2.59M 2.28M 3.30M 4.88M 9.98M
Net tangible assets - - -0.83M 3.28M 8.64M
Net receivables 0.17M 0.21M 0.40M 0.43M 0.73M
Inventory 0.41M 0.67M 0.29M 0.56M 0.41M
Accounts payable 4.24M 4.27M 1.43M 1.15M 0.74M
Accumulated other comprehensive income 0.72M 0.96M - 3.36M 3.15M
Non currrent assets other - -0.00M - - -
Non current assets total 0.00M 0.03M 0.21M 0.43M 0.37M
Long term debt total - - 0.00M 0.00M 0.00M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.29M -0.21M -0.03M -0.46M -0.14M
Change to liabilities 1.13M 0.11M -2.47M 2.67M -
Total cashflows from investing activities -0.29M -0.21M -0.03M -0.46M -0.14M
Net borrowings 0.94M 0.94M 0.94M 0.94M -
Total cash from financing activities 4.14M 4.14M 7.50M 7.23M 6.35M
Change to operating activities -0.05M 0.60M -0.67M 0.03M -
Net income -7.95M -5.41M -4.23M -4.82M -7.62M
Change in cash -1.63M -4.39M 1.67M 3.54M -0.27M
Begin period cash flow 3.67M 8.05M 6.39M 2.84M 3.12M
End period cash flow 2.03M 3.67M 8.05M 6.39M 2.84M
Total cash from operating activities -5.68M -4.18M -5.83M -3.22M -6.48M
Issuance of capital stock 3.20M - 7.50M 7.23M 6.81M
Depreciation 0.17M 0.15M 0.13M 0.07M 0.06M
Other cashflows from investing activities -0.14M -0.19M -0.01M -0.44M -0.07M
Change to inventory 0.27M -0.15M 0.07M -0.50M -0.51M
Change to account receivables 0.16M 0.30M 0.76M -1.40M 0.09M
Sale purchase of stock - 0.00M 7.50M 7.23M -0.46M
Other cashflows from financing activities 1.87M -0.21M 7.50M 7.23M 6.35M
Change to netincome 0.45M 0.21M 0.58M 0.74M -
Capital expenditures 0.15M 0.21M 0.02M 0.46M 0.13M
Change in working capital 1.50M 0.87M -2.32M 0.79M -0.25M
Stock based compensation 0.55M 0.20M 0.59M 0.48M 0.73M
Other non cash items -0.10M 0.15M 1.44M 1.16M 1.83M
Free cash flow -5.83M -4.38M -5.86M -3.68M -6.62M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AFP
Aft Pharmaceuticals Ltd		 0.05
1.41%		 3.60 29.92 18.18 1.48 4.37 2.05 18.56
VLS
Vita Life Sciences Ltd		 0.09
3.42%		 2.72 13.50 42.73 1.52 2.62 1.19 7.17
LGP
Little Green Pharma Ltd		 0.01
16.67%		 0.07 - 10.00 0.64 0.60 1.25 19.47
MVP
Medical Developments International Ltd		 -
-%		 0.44 40.00 166.67 1.06 0.79 0.57 7.45

Profile*

BOD Science Ltd

Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. The company operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. It engages in the development of cannabidiol and hemp products for consumers; and development and distribution of therapeutics medicinal cannabis products for medical markets. The company provides Flexofytol, an anti-inflammatory derived from a scientifically validated and clinically trialed turmeric extract that helps in improving joint pain and stiffness, joint health, limiting the ageing of cartilage, and reducing inflammation caused by mild arthritis; and Sedistress, a passion flower extract that reduces the symptoms of stress, anxiety, and insomnia, as well as contract manufacturing services. The company was formerly known as Bod Australia Limited and changed its name to Bod Science Limited in December 2022. Bod Science Limited was incorporated in 2014 and is based in Double Bay, Australia.

376 New South Head Road, Double Bay, NSW, Australia, 2028

61 2 9199 5018

https://bodscience.com

Name Title Year Born
Ms. Joanne Patterson CEO, Exec. Director & Member of Medical Advisory Board NA
Mr. Adrian Sturrock Chief Financial Officer NA
Mr. Craig Weller COO & Member of Medical Advisory Board NA
Dr. Adele Hosseini Chief Scientific Officer & Member of Medical Advisory Board NA
Mr. Alan Dworkin ACIS, BBus, CA Advisor NA
Mr. Stephen Kelly Company Sec. NA
Ms. Joanne Patterson CEO, Executive Director & Member of Medical Advisory Board NA
Mr. Craig Weller CTO & Member of Medical Advisory Board NA
Ms. Carlie Hodges Company Secretary NA
Ms. Joanne Patterson CEO, Executive Director & Member of Medical Advisory Board NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…